Invenomic Capital Management’s Rover Group, Inc. Class A Common Stock ROVR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,321,728
Closed -$6.49M 169
2023
Q2
$6.49M Sell
1,321,728
-1,177,464
-47% -$5.39M 0.33% 76
2023
Q1
$11.3M Buy
2,499,192
+39,586
+2% +$160K 0.64% 51
2022
Q4
$9.03M Sell
2,459,606
-786,334
-24% -$3.37M 0.61% 55
2022
Q3
$10.8M Sell
3,245,940
-109,293
-3% -$435K 0.93% 39
2022
Q2
$12.6M Buy
3,355,233
+477,633
+17% +$2.46M 0.89% 37
2022
Q1
$16.6M Buy
+2,877,600
New +$17.2M 1.77% 10

Other funds holding ROVR

Invenomic Capital Management's ROVR Position: Q3 2023 in Review

Invenomic Capital Management sold out of Rover Group, Inc. Class A Common Stock (ROVR) in Q3 2023, closing a stake of 1,321,728 shares — an estimated $6.49M sold.

Invenomic Capital Management first reported a position in ROVR in Q1 2022 and held it in 6 quarters. The position peaked at $16.6M in Q1 2022. 140 funds tracked by Wall St. Rank hold ROVR as of Q3 2023.

  • Invenomic Capital Management reported no remaining Rover Group, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • Invenomic Capital Management sold 1,321,728 Rover Group, Inc. Class A Common Stock shares in Q3 2023, an estimated $6.49M.
  • Invenomic Capital Management first reported a position in Rover Group, Inc. Class A Common Stock in Q1 2022 and held it in 6 quarters.
  • Invenomic Capital Management's Rover Group, Inc. Class A Common Stock position peaked at $16.6M in Q1 2022.
  • 140 funds tracked by Wall St. Rank held Rover Group, Inc. Class A Common Stock as of Q3 2023.

Based on Invenomic Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.